Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Anti-Counterfeiting Pharma Conference: PCI’s Ian Parsonage to Share his Expertise on Serialization

Philadelphia, USA  – Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) will be sharing its specialist Serialization expertise at the upcoming 3rd Anti-Counterfeiting Pharma conference (London Kensington Forum, March 7-8).

Read the rest of entry »

Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference

Oxford, UK – Immunocore Limited, a world-leading biotechnology company developing novel TCR-based biological drugs to treat cancer, infectious diseases and autoimmune diseases, announced today that it will present at the Cowen and Company 37th Annual Healthcare Conference in Boston, MA.

Read the rest of entry »

Oxford Immunotec Reports Fourth Quarter and Full Year 2016 Financial Results

UK & Marlborough, USA – Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced fourth quarter and full year 2016 financial results.

Read the rest of entry »

Cell Lines & Media for Difficult to Culture Tumor Types

AMSBIO has introduced a new range of cancer cell line models and culture media for the most difficult to culture tumor types where no models may exist.

Read the rest of entry »

Caldan Therapeutics Announces Key Appointment

 Edinburgh, UK – Caldan Therapeutics, a spin-out company from the Universities of Glasgow and Southern Denmark, which specialises in developing novel therapeutics targeting free fatty acid receptors for the treatment of metabolic disease, including Type 2 Diabetes and non-alcoholic steatohepatitis (NASH), is pleased to announce the appointment of Dr Mark Payton as Chief Executive Officer (CEO).

Read the rest of entry »

Oxford Immunotec to Present at the Cowen and Company 37th Annual Health Care Conference

OXFORD, United Kingdom and MARLBOROUGH, Mass., February 22, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017, at 3:20 p.m. EST at the Boston Marriott Copley Place in Boston.

Read the rest of entry »

SRG 2017 Salary Survey now available

The latest figures, the deepest insights, the most comprehensive expertise.

Read the rest of entry »

Reach Separations Turns 5!

February the 13th saw Reach Separations celebrate five years of laboratory occupation at Biocity Nottingham!

Read the rest of entry »

Oxford Immunotec Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for February 28, 2017

OXFORD, United Kingdom and MARLBOROUGH, Mass., February 14, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that it plans to release fourth quarter and full year 2016 financial results after the close of the market on Tuesday, February 28, 2017. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Rick Altieri, Chief Financial Officer, will host a conference call to review the Company's results at 5:00 p.m. Eastern Time the same day. The call will be concurrently webcast.

Read the rest of entry »

NIHR Brain Injury Healthcare Technology Co-operative – Seedcorn Funding Competition 2016/2017 – FUNDING CALL ROUND 2 NOW OPEN

The NIHR Brain Injury Healthcare Technology Co-operative is pleased to announce the second round of its second national competition. The seed funding call (up to £10,000) is for the early development of novel technology-based solutions applicable to the brain injury pathway, from prevention of injury all the way through to technologies for independent living.  Applications are invited from academic institutions, NHS Trusts, third sector organisations and SME’s.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.

Don't forget about the 'wandering kitchens' near No. 99 on Milton Park on Thursday lunchtime!